Showing results (6131-6140 of 10,080) with videos related to
Sort By:
Pageof 1,008
Current Pharmaceutical Design|June 2, 2012
Protein-protein interactions: network analysis and applications in drug discoveryJennyfer Bultinck, Sam Lievens, Jan TavernierCurrent Pharmaceutical Design|November 15, 2011
Prodrugs for targeted tumor therapies: recent developments in ADEPT, GDEPT and PMTLutz F Tietze, Kianga SchmuckCurrent Pharmaceutical Design|November 15, 2011
Prodrugs in photodynamic anticancer therapyRobert Musiol, Maciej Serda, Jaroslaw PolanskiCurrent Pharmaceutical Design|November 15, 2011
Lipid lowering drugs and gallstones: a therapeutic option?Eirini Lioudaki, Emmanuel S Ganotakis, Dimitri P MikhailidisCurrent Pharmaceutical Design|November 15, 2011
Liver enzymes: potential cardiovascular risk markers?Eirini Lioudaki, Emmanuel S Ganotakis, Dimitri P MikhailidisCurrent Pharmaceutical Design|November 15, 2011
Role of physician gender in the quality of care of cardiometabolic diseasesI Gouni-Berthold, H K BertholdCurrent Pharmaceutical Design|August 8, 2018
Gene Silencing using siRNA for Preventing Liver Ischaemia-Reperfusion InjuryH Susana Marinho, Paulo Marcelino, Helena Soares, et al.Current Pharmaceutical Design|August 14, 2018
The Possible Impact of Hyperuricemia on Serum Soluble Receptor for Advanced Glycation end Products (sRAGE) Levels in Teenagers: A Case Control StudyMarta Lemiesz, Edyta Tenderenda-Banasiuk, Dorota Sosnowska, et al.Current Pharmaceutical Design|August 14, 2018
Redox Sensitive Polysaccharide Based Nanoparticles for Improved Cancer Treatment: A Comprehensive ReviewErfaneh Ghassami, Jaleh Varshosaz, Somayeh TaymouriCurrent Pharmaceutical Design|September 20, 2018
The Value of Urinary Cystatin C Level to Predict Neonatal Kidney InjuryNastaran Khosravi, Masoud Zadkarami, Farhad Chobdar, et al.Pageof 1,008